Search - tctmd.com

Displaying 141 - 157 of 157

Sort: Relevancy | Date

News Daily News

Los Nuevos Anticoagulantes Orales Superan a la Warfarina en la Prevención del ACV en pacientes con Fibrilación Auricular

May 04, 2012

Presentation

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

Presenter: Corey S. Miller

May 03, 2012

News Daily News

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

L.A. McKeown

March 12, 2012

News Daily News

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

L.A. McKeown

March 12, 2012

Presentation

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Presenter: Hans-Christoph Diener

March 08, 2012

Presentation

Apixaban frente a Aspirina en Pacientes con Fibrilación Auricular y Antecedentes de ACV o AIT

Presenter: Hans-Christoph Diener

March 08, 2012

News Daily News

Hope Renewed for Novel Anticoagulant Use in ACS

Caitlin E. Cox

October 05, 2011

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Caitlin E. Cox

August 10, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

June 24, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Jason Kahn

February 09, 2011

Advertisement

Los Nuevos Anticoagulantes Orales Superan a la Warfarina en la Prevención del ACV en pacientes con Fibrilación Auricular

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Apixaban frente a Aspirina en Pacientes con Fibrilación Auricular y Antecedentes de ACV o AIT

Hope Renewed for Novel Anticoagulant Use in ACS

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

ESC Congress 2011: Drugs, Devices Work Together

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Apixaban Increases Major Bleeding in High-Risk ACS Patients

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content